亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

氯法拉濱cas:123318-82-1

 
 
單價(jià) 1.00 / 千克對(duì)比
銷量 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫存 1000千克起訂1千克
品牌 康寶泰
型號(hào) cas:123318-82-1
規(guī)格 25
過期 長(zhǎng)期有效
更新 2013-01-21 10:44
 

武漢康寶泰精細(xì)化工有限公司武昌一部

企業(yè)會(huì)員第13年
資料未認(rèn)證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2015-09-09
  • 付經(jīng)理 (女士)   銷售經(jīng)理
詳細(xì)說明

氯法拉濱
別名:克羅他濱 ,;,;氯法拉濱;克羅拉濱;
英文名:Clofarabine
cas:123318-82-1
分子式:C10H11CLFN5O3
分子量:303.68
總雜質(zhì)<0.2%
單一最大雜質(zhì)<0.1%
外觀:白色結(jié)晶粉末
用途:具有潛在廣譜抗腫瘤特性。治療結(jié)直腸癌、肺癌、乳腺癌、腎癌、宮頸癌、皮膚癌、膀胱癌、口腔癌等,對(duì)治療急性白血病有很好的療效。具有潛在適應(yīng)性,包括很多實(shí)體瘤和一些免疫性疾病。
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
椰子醛CAS號(hào): 104-61-0 尼可地爾CAS號(hào): 65141-46-0 椰子醛CAS號(hào): 104-61-0 尼可地爾CAS號(hào): 65141-46-0 對(duì)肼基苯磺酰胺出現(xiàn)被限制詞語CAS號(hào): 17852-52-7 對(duì)甲氧基乙基苯酚CAS號(hào):56718-71-9 4-二甲氨基苯甲酸CAS號(hào): 619-84-1
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |